(Q37221118)

19 August 2017

title

Prognostic implication of endometriosis in clear cell carcinoma of the ovary (English)

1 reference

19 August 2017

1 reference

1 reference

J P Orezzoli

1

1 reference

19 August 2017

A H Russell

2

1 reference

19 August 2017

E Oliva

3

1 reference

19 August 2017

M G Del Carmen

4

1 reference

19 August 2017

J Eichhorn

5

1 reference

19 August 2017

A F Fuller

6

1 reference

19 August 2017

language of work or name

English

0 references

publication date

18 July 2008

1 reference

19 August 2017

1 reference

19 August 2017

volume

110

1 reference

19 August 2017

issue

3

1 reference

19 August 2017

page(s)

336-344

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.025

19 August 2017

1 reference

Postmenopausal endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.025

Ovarian clear cell adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.025

Clear cell carcinoma of the ovary: a study of 59 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.025

Clear cell epithelial ovarian cancer (mesonephroid): bad prognosis only in early stages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.025

Clear cell adenocarcinoma of the ovary: a clinical analysis and comparison with serous carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.025

Lack of improved survival plus increase in thromboembolic complications in patients with clear cell carcinoma of the ovary treated with platinum versus nonplatinum-based chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.025

Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.025

Endometrioid carcinoma of the ovary and endometriosis: the association in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.025

Ovarian and extraovarian endometriosis-associated cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.025

Malignant transformation of ovarian endometriosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.025

Prevalence of endometriosis in malignant epithelial ovary tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.025

Endometriosis-associated ovarian cancer: a clinicopathologic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.025

Endometriosis and the neoplastic process

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.025

Prevalence of endometriosis in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.025

Nonparametric Estimation from Incomplete Observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.025

Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.025

Origins and molecular pathology of ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.025

Ovarian endometriosis associated with ovarian carcinoma: a clinicopathological and immunohistochemical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.025

Endometrioid and clear cell carcinoma of the ovary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.025

Ovarian atypical endometriosis: its close association with malignant epithelial tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.025

Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis: a critical analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.025

Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.025

Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.025

Expression of hepatocyte nuclear factor-1beta (HNF-1beta) in clear cell tumors and endometriosis of the ovary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.025

Monoclonal origin of endometriotic cysts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.025

Patterns of loss of heterozygosity at 10q23.3 and microsatellite instability in endometriosis, atypical endometriosis, and ovarian carcinoma arising in association with endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.025

Molecular genetic evidence that endometriosis is a precursor of ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.025

Endometriosis and ovarian cancer: thoughts on shared pathophysiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.025

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.025

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.025

Cancer risk after a hospital discharge diagnosis of endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.025

Development of an ovarian cancer symptom index: possibilities for earlier detection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.025

Histologic transformation of benign endometriosis to early epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.025

Endometrioid adenocarcinoma of the ovary and its relationship to endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.025

Postoperative whole abdominal radiotherapy in clear cell adenocarcinoma of the ovary.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.025

Malignant extraovarian endometriosis: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.025

Endometrial adenocarcinoma arising from endometriosis of the rectosigmoid colon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.025

Hormone Therapy and the Impact of Estrogen Intake on the Risk of Ovarian Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.025

Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.025

Menopausal hormone therapy and risk of ovarian cancer: systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.025

Ovarian cancer and hormone replacement therapy in the Million Women Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.025

10.1016/J.YGYNO.2008.05.025

7 January 2021

Identifiers

DOI

1 reference

19 August 2017

1 reference